Merck drug reduces chronic cough but taste issues may cloud prospects

Merck drug reduces chronic cough but taste issues may cloud prospects

More reads

• Merck drug reduces cough frequency but taste alterations could cloud prospects. (STAT Plus)
• Coronavirus turmoil throws biotechnology IPOs into question. (Wall Street Journal)
• The White House is pinning its hopes on health tech to save the day. Can it deliver? (STAT)
• Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs. (STAT)